Wood A W, Levin W, Chang R L, Huang M T, Ryan D E, Thomas P E, Lehr R E, Kumar S, Koreeda M, Akagi H, Ittah Y, Dansette P, Yagi H, Jerina D M, Conney A H
Cancer Res. 1980 Mar;40(3):642-9.
The biological activities of benzo(a)pyrene, cyclopenta(c,d)pyrene, and 12 other structurally related compounds were assessed by mutagenicity studies with bacterial and mammalian cells and/or skin tumorigenicity studies with mice. The ability of the parent hydrocarbons to be metabolically activated to mutagenic products was examined in strains TA98 and TA100 of Salmonella typhimurium, using 3 experimental protocols. In each case, cyclopenta(c,d)pyrene was metabolically activated to products mutagenic to the bacteria to a greater extent than was benzo(a)pyrene. However, 7,8-dihydrobenzo(a)pyrene and 0,10-dihydrobenzo(e)pyrene were the best substrates for metabolic activation to bacterial mutagens. Highly purified epoxide hydrase added to a purified and reconstituted monooxygenase system readily abolished the mutagenic activity observed in strain TA100 of S. typhimurium when cyclopenta(c,d)pyrene was the substrate, but not when benzo(a)pyrene was the substrate. Inherent mutagenicity of several epoxides of the hydrocarbons generally paralleled the ability of their potential metabolic precursors to be activated to mutagens. 1-Pyrenyloxirane and 10,11-dihydrocycloheptapyrene 8,9-oxide were highly mutagenic in strains TA98 and TA100 of S. typhimurium, and in the former strain these activities were comparable to that observed with 9,10-epoxy-7,8,9,10-tetrahydrobenzo(a)pyrene, 4-Pyrenyloxirane was significantly less mutagenic than was 1-pyrenyloxirane in both strains of bacteria and in mammalian cells. Benzo(a)pyrene was over 20 times more tumorigenic than was cyclopenta-(c,d)pyrene, and it was the most potent of the 11 compounds tested for tumor-initiating activity in 2-stage initiation-promotion experiments on the skin of mice. Cyclopenta(c,d)pyrene had tumor-initiating activity comparable to that of benzo-(a)anthracene, but it was significantly less active than chrysene. Thus, contrary to inferences made from its high mutagenic activity, cyclopenta(c,d)pyrene is a weak tumor initiator on mouse skin.
通过细菌和哺乳动物细胞的致突变性研究以及小鼠皮肤致癌性研究,评估了苯并(a)芘、环戊(c,d)芘和其他12种结构相关化合物的生物活性。使用3种实验方案,在鼠伤寒沙门氏菌TA98和TA100菌株中检测了母体碳氢化合物代谢活化为致突变产物的能力。在每种情况下,环戊(c,d)芘代谢活化为对细菌有致突变性的产物的程度都比苯并(a)芘更大。然而,7,8 - 二氢苯并(a)芘和0,10 - 二氢苯并(e)芘是代谢活化为细菌诱变剂的最佳底物。当环戊(c,d)芘为底物时,向纯化并重组的单加氧酶系统中添加高度纯化的环氧化物水解酶能轻易消除在鼠伤寒沙门氏菌TA100菌株中观察到的诱变活性,但当苯并(a)芘为底物时则不能。这些碳氢化合物的几种环氧化物的固有致突变性通常与其潜在代谢前体活化为诱变剂的能力相当。1 - 芘环氧乙烷和10,11 - 二氢环庚并[a]芘8,9 - 氧化物在鼠伤寒沙门氏菌TA98和TA100菌株中具有高度致突变性,并且在前一种菌株中,这些活性与9,10 - 环氧 - 7,8,9,10 - 四氢苯并(a)芘所观察到的活性相当。在两种细菌菌株和哺乳动物细胞中,4 - 芘环氧乙烷的致突变性明显低于1 - 芘环氧乙烷。苯并(a)芘的致癌性比环戊(c,d)芘高20倍以上,并且在小鼠皮肤的两阶段启动 - 促进实验中,它是所测试的11种化合物中肿瘤启动活性最强的。环戊(c,d)芘具有与苯并(a)蒽相当的肿瘤启动活性,但明显低于屈。因此,与其高致突变活性所推断的情况相反,环戊(c,d)芘在小鼠皮肤上是一种弱肿瘤启动剂。